Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
EMERYVILLE, Calif., May 03, 2018 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich’s iconic Z11 molecule was developed using Amyris’s disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.
“We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris. “Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource.”
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]
